Sophiris Bio Inc T.SHS

Primary Symbol: SPHS

Healthcare Biotechnology

Sophiris Bio Inc is a clinical-stage biopharmaceutical company. It focuses on the development of products for the treatment of urological diseases. The company's product portfolio includes topsalysin (PRX302), for the treatment of lower urinary tract symptoms of benign prostatic hyperplasia (BPH), as well as for the treatment of localized low to intermediate risk prostate cancer. Topsalysin is a genetically modified recombinant protein which is selectively activated by enzymatically active prostate-specific antigen (PSA), which is only present in the prostate, leading to localized cell death and tissue disruption without damage to neighboring tissue and nerves. Geographically all the operations of the company are functioned in the United States.

EXPM:SPHS - Post by User

Sophiris Bio Inc

Bullboard Posts

Comment by sandufon Mar 13, 2013 3:57pm

138 Views

Post# 21124700

RE: RE: US & TSX Listing

Thanks cabbie & p.yu for the explanations and projections. Can't say that I feel any better but at least I now have a much better idea of what to expect. If I can live as long as Methuselah maybe I'll make some money! In the meantime I'll just sit back and roll with the punches and not buy any more "green" bananas.

Thanks again,

sanduf

Bullboard Posts

Consumer advocacy law firm investigates Microsoft over X-Box data concerns